100 related articles for article (PubMed ID: 2554788)
1. Expression of c-erbA in human hepatocellular carcinomas.
Arbuthnot P; Kew M; Parker I; Fitschen W
Anticancer Res; 1989; 9(4):885-7. PubMed ID: 2554788
[TBL] [Abstract][Full Text] [Related]
2. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.
Arbuthnot P; Kew M; Fitschen W
Anticancer Res; 1991; 11(2):921-4. PubMed ID: 1648336
[TBL] [Abstract][Full Text] [Related]
3. c-met mRNA overexpression in human hepatocellular carcinoma.
Boix L; Rosa JL; Ventura F; Castells A; Bruix J; Rodés J; Bartrons R
Hepatology; 1994 Jan; 19(1):88-91. PubMed ID: 8276372
[TBL] [Abstract][Full Text] [Related]
4. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
5. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
6. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
7. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
[TBL] [Abstract][Full Text] [Related]
8. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue.
Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S
J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833
[TBL] [Abstract][Full Text] [Related]
9. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
[TBL] [Abstract][Full Text] [Related]
10. Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis.
Sakai M; Okuda A; Hatayama I; Sato K; Nishi S; Muramatsu M
Cancer Res; 1989 Oct; 49(20):5633-7. PubMed ID: 2507134
[TBL] [Abstract][Full Text] [Related]
11. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma.
de Thé H; Marchio A; Tiollais P; Dejean A
Nature; 1987 Dec 17-23; 330(6149):667-70. PubMed ID: 2825037
[TBL] [Abstract][Full Text] [Related]
12. Analysis of c-myc expression in a human hepatoma cell line.
Huber BE; Thorgeirsson SS
Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
[TBL] [Abstract][Full Text] [Related]
13. Expression of the c-met protooncogene in human hepatocellular carcinoma.
Suzuki K; Hayashi N; Yamada Y; Yoshihara H; Miyamoto Y; Ito Y; Ito T; Katayama K; Sasaki Y; Ito A
Hepatology; 1994 Nov; 20(5):1231-6. PubMed ID: 7927256
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
15. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
Smit-McBride Z; Privalsky ML
Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
[TBL] [Abstract][Full Text] [Related]
16. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
Wu B; Wang M; You W; Yang S
Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
[TBL] [Abstract][Full Text] [Related]
18. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
19. The lca as an onco-fetal gene: its expression in human fetal liver.
Shiozawa M; Ochiya T; Hatada I; Imamura T; Okudaira Y; Hiraoka H; Matsubara K
Oncogene; 1988 May; 2(5):523-6. PubMed ID: 2836781
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]